This educational initiative will enhance dermatologists' and surgeons' knowledge, clinical skills, and confidence in recognizing patients who may benefit from adjuvant systemic therapy and selecting individualized, appropriate agents to improve outcomes for patients with stage IIB-IV resectable melanoma.
Gastrointestinal and Hematologic TEAEs Related to ADC Therapy in Gynecologic Cancers
Managing Pulmonary and Cardiac Adverse Events Related to ADC Therapy in Breast Cancer
Risk Reduction and Management Protocols for Gastrointestinal Adverse Events With ADC Therapy in Breast Cancer
Hematologic Adverse Events With ADCs in Breast Cancer: Optimal Management Strategies
Managing ADC-Related Pulmonary and Cardiac AEs in NSCLC
Optimal Management of ADC-Related Gastrointestinal AEs in NSCLC
ADC-Related Hematologic Adverse Events
Emerging ADC Therapies for NSCLC: Anticipating AEs Reported in Clinical Trials
ADCs in Gynecologic Cancers: Managing Pulmonary and Cardiac TEAEs
ADCs on the Horizon for Breast Cancer: Managing Treatment-Emergent Toxicities
What Are the Latest Updates on the Clinical and Economic Impact of AF?
What Are the 10 Key Takeaways for the 2023 ACC/AHA/ACCP/HRS Guideline for AF?
How Do We Best Incorporate Latest Guidance in Optimizing Care for the Patient with AF?
AF Screening, Risk Factors, and Diagnosis: What’s New?
Anticoagulation Management of AF: What Has Changed?
Latest Guidance on Anticoagulation in Special AF Patient Populations
Impact of Social Determinants of Health on Management of AF
Latest Guidance on Anticoagulation in AF Patient Populations with Comorbidities
Case Study - New Guideline Recommendations into Clinical Practice for the Patient with AF
Cracking the CRS Code in Myeloma: Insights from a Comprehensive Case Review
Create your
podcast in
minutes
It is Free
RenaissanceOnlineRadio.com
Men in Lead Aprons
Denver Underground
Exercise: Learn To Love (Or At Least Like) It
NASACast Video